Halozyme Therapeutics, Inc. (HALO) Misses Q4 EPS by 2c

February 27, 2014 4:36 PM

Halozyme Therapeutics, Inc. (NASDAQ: HALO) reported Q4 EPS of ($0.19) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found